Kingsview Wealth Management, LLC Pfizer Inc Transaction History

Kingsview Wealth Management, LLC

$3.97 Billion
Q2 2024

A detailed history of Kingsview Wealth Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Kingsview Wealth Management, LLC holds 295,451 shares of PFE stock, worth $8.55 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

295,451

Previous 91,459 223.04%

Holding current value

$8.55 Million

Previous $2.54 Million 225.82%

% of portfolio

0.21%

Previous 0.07%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $5.15 Million - $6.04 Million	203,992 Added 223.04%	295,451 $8.27 Million
Q1 2024 May 09, 2024	SELL	$25.89 - $29.73 $165,126 - $189,617	-6,378 Reduced 6.52%	91,459 $2.54 Million
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $317,009 - $411,760	-12,132 Reduced 11.03%	97,837 $2.82 Million
Q3 2023 Nov 07, 2023	BUY	$32.09 - $37.51 $199,022 - $232,637	6,202 Added 5.98%	109,969 $3.65 Million
Q2 2023 Aug 10, 2023	SELL	$36.12 - $41.79 $33,988 - $39,324	-941 Reduced 0.9%	103,767 $3.81 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $95,363 - $124,148	-2,421 Reduced 2.26%	104,708 $4.27 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $411,613 - $537,315	9,859 Added 10.14%	107,129 $5.49 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $329,337 - $402,038	7,526 Added 8.39%	97,270 $4.26 Million
Q2 2022 Aug 16, 2022	SELL	$46.53 - $55.17 $1.34 Million - $1.58 Million	-28,694 Reduced 24.23%	89,744 $4.71 Million
Q1 2022 Feb 08, 2024	BUY	$45.75 - $56.69 $1.09 Million - $1.35 Million	23,838 Added 24.37%	121,675 $6.3 Million
Q4 2021 Feb 17, 2022	BUY	$41.32 - $61.25 $1.58 Million - $2.35 Million	38,306 Added 47.8%	118,438 $6.99 Million
Q3 2021 Dec 03, 2021	BUY	$39.25 - $50.42 $66,018 - $84,806	1,682 Added 2.14%	80,132 $3.45 Million
Q2 2021 Aug 17, 2021	BUY	$35.91 - $40.68 $87,907 - $99,584	2,448 Added 3.22%	78,450 $3.1 Million
Q1 2021 May 24, 2021	SELL	$33.49 - $37.77 $395,952 - $446,554	-11,823 Reduced 13.46%	76,002 $2.76 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $401,573 - $510,634	11,998 Added 15.82%	87,825 $3.23 Million
Q3 2020 Nov 19, 2020	BUY	$31.75 - $37.25 $446,532 - $523,884	14,064 Added 22.77%	75,827 $2.78 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $1.5 Million - $1.82 Million	-49,897 Reduced 44.69%	61,763 $2.02 Million
Q1 2020 May 11, 2020	BUY	$27.03 - $38.62 $425,073 - $607,338	15,726 Added 16.39%	111,660 $3.65 Million
Q4 2019 Jan 31, 2020	BUY	$32.92 - $37.36 $2.89 Million - $3.28 Million	87,832 Added 1084.08%	95,934 $3.76 Million
Q4 2019 Jan 30, 2020	SELL	$32.92 - $37.36 $2.72 Million - $3.09 Million	-82,631 Reduced 91.07%	8,102 $293,000
Q3 2019 Jan 29, 2020	BUY	$32.49 - $42.13 $64,817 - $84,049	1,995 Added 2.25%	90,733 $3.26 Million
Q2 2019 Jan 29, 2020	BUY	$36.98 - $41.52 $72,221 - $81,088	1,953 Added 2.25%	88,738 $3.84 Million
Q1 2019 Jan 29, 2020	BUY	$37.5 - $41.2 $331,387 - $364,084	8,837 Added 11.34%	86,785 $3.69 Million
Q4 2018 Jan 29, 2020	BUY	$38.47 - $43.86 $269,674 - $307,458	7,010 Added 9.88%	77,948 $3.4 Million
Q3 2018 Jan 29, 2020	BUY	$34.47 - $41.81 $196,444 - $238,275	5,699 Added 8.74%	70,938 $3.13 Million
Q2 2018 Jan 29, 2020	BUY	$32.98 - $35.16 $115,397 - $123,024	3,499 Added 5.67%	65,239 $2.37 Million
Q1 2018 Jan 29, 2020	BUY	$31.91 - $37.02 $1.71 Million - $1.99 Million	53,638 Added 662.03%	61,740 $2.19 Million
Q4 2017 Jan 29, 2020	SELL	$33.26 - $35.29 $53,847 - $57,134	-1,619 Reduced 16.65%	8,102 $293,000
Q3 2017 Jan 29, 2020	BUY	$31.0 - $34.15 $109,461 - $120,583	3,531 Added 57.04%	9,721 $347,000
Q2 2017 Jan 29, 2020	SELL	N/A	-1,354 Reduced 17.95%	6,190 $208,000
Q1 2017 Jan 29, 2020	BUY	N/A	7,544	7,544 $258,000

Others Institutions Holding PFE

# of Institutions

3,222

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $162B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.

Account

Kingsview Wealth Management, LLC Pfizer Inc Transaction History